The efficacy of Golimumab against non-infectious uveitis: a PRISMA-compliant systematic review and meta-analysis.
Katsuya OkadaYi ZhouNoriyasu HashidaTatsuya TakagiYu-Shi TianPublished in: Ocular immunology and inflammation (2022)
This study was limited by the use of non-RCT designs, limited sample sizes for outcomes, and heterogenetic underlying diseases. Our results suggest that GOL is effective against NIU. However, further evidence and analyses are required. (Funding: None; PROSPERO registration: CRD42021266214.).